معرفی
Carine Michiels is a prominent researcher in the field of cellular biochemistry and cancer research at the University of Namur. She holds a Doctor of Science degree from the University of Namur (1989) and has dedicated her career to studying cancer biology, radiation therapy, and tumor microenvironment interactions. Her work focuses on understanding hypoxia-driven tumor progression, nanoparticle-mediated radiosensitization, and macrophage reprogramming in cancer therapy. Michiels leads several high-impact projects, including the PROTHER-WAL initiative exploring proton therapy in oncology. She has supervised over 118 research works and received the prestigious Bacq and Alexander Prize (2022) for her contributions to radiation research.
- Affiliations: Namur Research Institute for Life Sciences, Laboratory of Cellular Biochemistry and Biology
- Education: Doctor of Science in Cellular Degeneration (1989), Master in Biology (1985)
Her research interests span cancer biology, radiobiology, and translational oncology. Key areas include the role of cycling hypoxia in tumor inflammation, gold nanoparticle applications in therapy, and the interplay between radiation and immune responses. Michiels has authored over 240 publications and actively participates in international conferences, thesis juries, and collaborative research networks across Europe.
Notable achievements include groundbreaking studies on FLASH radiotherapy mechanisms and the development of theranostic platforms combining nanoparticles with radionuclides. Her lab investigates novel therapeutic strategies targeting metastasis and tumor-associated macrophages, with implications for personalized cancer treatment.
